Percutaneous Drainage Catheters Market Size, Share, Industry, Forecast and outlook 2026-2035

Percutaneous Drainage Catheters Market Overview

The global percutaneous drainage catheters market is estimated at US$1.32 billion in 2025 and is projected to reach approximately US$ 2.22 billion by 2035, growing at a CAGR of 5.3% during the forecast period. The market covers biliary drainage catheters, centesis drainage catheters, multipurpose drainage catheters, nephrostomy drainage catheters and other image guided drainage devices used across abdominal, pelvic and other fluid collection procedures. Percutaneous drainage involves placing a catheter through the skin under ultrasound, CT, fluoroscopy or other imaging guidance to drain abscesses, bile, urine, pleural fluid, ascites or other abnormal collections.

The market is expanding because healthcare systems are moving toward minimally invasive treatment of abscesses, biliary obstruction, urinary obstruction, post surgical collections and high risk surgical patients. Image guided percutaneous drainage can reduce the need for open surgical drainage, shorten recovery time and support treatment in patients who are poor surgical candidates. Clinical guidance from interventional radiology sources shows strong procedural relevance, with percutaneous drainage curing infected fluid or air collections in more than 80% of patients. Failure occurs in 5% to 10% of patients, while major complications such as bacteremia occur in 2% to 5% of cases and septic shock occurs in 1% to 2% of cases.

Demand is also supported by disease burden. Kidney stones affect up to 12% of the population during a lifetime and recurrence rates approach 50% at 10 years, creating ongoing need for urologic intervention and nephrostomy access in obstructive cases. Acute cholecystitis and biliary obstruction also support biliary drainage demand, especially among patients who are elderly, septic, jaundiced or unsuitable for immediate surgery. In the United States, around 10,000 nonsurgical acute cholecystitis candidates per year are reported to receive gallbladder decompression through percutaneous cholecystostomy.

From 2026 onward, market growth will be shaped by four forces: rising interventional radiology procedure volumes, smaller and more stable locking catheter designs, outpatient and home based drainage management and demand from Asia Pacific hospitals expanding minimally invasive image guided care. Suppliers that combine catheter stability, kink resistance, securement image-guideddesign, drainage efficiency and broad product coverage across biliary, nephrostomy and abscess drainage will gain stronger positions.

Key Takeaways

• Minimally invasive procedures are accelerating demand for image-guided drainage catheters across hospitals.
• Biliary drainage catheters remain the largest revenue-generating product segment.
• Asia-Pacific is the fastest-growing region, driven by expanding interventional radiology infrastructure.
• Device innovation (anti-kinking, locking mechanisms, mini pigtail, dual-lumen designs) is improving procedural outcomes.
• Outpatient and home-based drainage management are creating new growth opportunities for manufacturers.
• Nephrostomy and abscess drainage are emerging as high-growth clinical applications due to rising disease burden.
• Manufacturers with broad portfolios, strong catheter performance, and complete drainage solutions are best positioned to gain market share.

Percutaneous Drainage Catheters Market Scope

     For More Insights Request Request Free Sample

Market Dynamics

Advancement in the Percutaneous Drainage Catheter devices is expected to drive market growth.

The 3D Pigtail Drainage Catheter Needle consists of a hollow-style needle within a plastic catheter is a new drainage catheter designed to achieve faster and more complete evacuation of various fluid collections from the body, including ascites and pleural effusion cysts and abscesses, amongst others. Moreover, In vitro, the proposed dual-lumen drainage catheter with dedicated flush lumen irrigation increased the evacuation of complicated fluid collections. The two prototype catheters (20- and 28-F) were created by incorporating a customized infusion lumen within the large-bore conventional drainage catheter wall, which facilitated simultaneous irrigation of the drainage lumen and the targeted collection via inward outward-facing infusion side holes. Thus, the market is expected to drive in the forecast period from the above statements.

Complications associated with the Percutaneous Drainage Catheters are expected to hamper the market growth.

The catheter used to drain a percutaneous abscess may become clogged or misplaced, necessitating manipulation or catheter replacement. Similarly, a big or complex fluid collection may necessitate the use of more than one abscess drain. If contrast material is injected during the procedure, there is a small chance of an allergic reaction. Percutaneous abscess drainage can occasionally cause injury to a nearby organ. Bleeding may occur on occasion. Thus, the market is expected to hamper the forecast period from the above statements.

Biliary Drainage Catheters segment is expected to hold the largest market share in percutaneous drainage catheters market

The biliary drainage catheters segment is expected to dominate in 2021. The segment benefits because internal-external PBD includes improved catheter security relative to external drainage, avoidance of a drainage bag, easy catheter exchange over a guidewire, and excellent access for adjunctive treatment of benign or malignant strictures. Moreover, the procedure follows, and an external biliary drainage catheter goes through the skin and into bile ducts. It is placed above the blockage. After this procedure, the catheter comes out of the body, attached to a drainage bag. Therefore, it has increased the demand for the product. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Share

North America region holds the largest market share in the global percutaneous drainage catheters market

North America accounted for the highest revenue share. The increasing prevalence of kidney stones, well-established infrastructure, increasing demand and technological advancement in the devices, and product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, The American Urological Association states that kidney stones affect up to 12% of the population sometime during their lifetime. With over 325 million people in the United States, numbers suggest that approximately 39 million Americans will experience a kidney stone at some point in their lifetime. Moreover, Merit Medical announced the commercial launch of the ReSolve Mini Locking Drainage Catheter, the newest addition to Merit's groundbreaking ReSolve Locking Drainage Catheters range. The ReSolve Micro is designed for percutaneous fluid drainage from body cavities. Its mini pigtail design is up to 42% smaller than the conventional ReSolve Locking Drainage Catheter pigtail, allowing the catheter to be put into small fluid pockets. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Market Key Players

Major key players in the percutaneous drainage catheters market are Cook Medical, Becton, Dickinson and Company, Merit Medical Systems Inc., Boston Scientific Corp, Teleflex Incorporated, Medical Components, Inc., Angiplast Pvt. Ltd., Argon Medical Devices, Inc., and other players.

Cook Medical

Company Overview

Cook Medical is a global leader in minimally invasive medical devices and one of the most recognized manufacturers of percutaneous drainage catheters. The company's Interventional Radiology division develops drainage solutions used in biliary, nephrostomy, abscess, and multipurpose drainage procedures. Its products are widely adopted by hospitals and interventional radiologists worldwide.

Percutaneous Drainage Portfolio

• Multipurpose drainage catheters
• Biliary drainage catheters
• Nephrostomy catheters
• Drainage access sets
• Guidewires and introducers
• Interventional radiology accessories

Strategic Position

Cook Medical continues to strengthen its leadership through physician-focused product innovation, minimally invasive technologies, and a comprehensive portfolio supporting image-guided drainage procedures.

Teleflex Incorporated

Company Overview

Teleflex is a global medical technology company offering a broad portfolio of vascular access, interventional, surgical, and critical care products. Through its Interventional business, the company provides advanced drainage catheter systems designed for precise placement, improved patient safety, and enhanced procedural efficiency.

Percutaneous Drainage Portfolio

• Percutaneous drainage catheters
• Access needles
• Dilators
• Guidewire systems
• Drainage kits
• Interventional access devices

Strategic Position

Teleflex focuses on expanding minimally invasive treatment options while leveraging continuous product innovation and global commercial reach to strengthen its position in interventional medicine.

BD (Becton, Dickinson and Company)

Company Overview

BD is one of the world's largest medical technology companies, supplying advanced interventional products for hospitals and healthcare providers globally. Its drainage catheter portfolio supports image-guided procedures across radiology, oncology, and critical care, emphasizing procedural safety, precision, and workflow efficiency.

Percutaneous Drainage Portfolio

• Drainage catheter systems
• Interventional access devices
• Introducer systems
• Procedure kits
• Imaging-compatible accessories
• Vascular access technologies

Strategic Position

BD combines manufacturing scale, clinical expertise, and continuous innovation to support the growing adoption of minimally invasive drainage procedures worldwide.

Key Developments

• May 2026: Merit Medical Systems highlighted continued advancements in its ReSolve® Drainage Catheter portfolio and Aspira® drainage systems through its 2025 Annual Report, emphasizing improved catheter securement technologies, enhanced drainage efficiency, and broader support for minimally invasive image-guided drainage procedures. The company also reinforced R&D efforts around long-term drainage management and home-based patient care solutions.
• April 2026: Merit Medical Systems reported ongoing innovation across its percutaneous drainage product line, including the ReSolve ConvertX® Stent System, ReSolve Mini™ Locking Drainage Catheter, and One-Step® Drainage Catheters. The developments focused on catheter stability, ease of placement, and improved fluid evacuation performance for interventional radiology applications.
• March 2026: Industry-wide technological advancements accelerated the adoption of next-generation percutaneous drainage catheters featuring anti-kinking designs, enhanced catheter materials, improved securement systems, and optimized drainage flow characteristics. Manufacturers are increasingly focused on minimally invasive and outpatient drainage solutions to improve procedural outcomes and patient comfort.

Image-Guided Minimally Invasive Drainage Adoption 

Percutaneous drainage catheters are gaining demand because image-guided procedures have become the preferred minimally invasive option for many abscesses and abnormal fluid collections. Interventional radiologists use ultrasound, CT or fluoroscopy to place catheters through a small skin puncture and avoid the morbidity of open surgical drainage in suitable patients. This is clinically important because many drainage candidates are elderly, septic, immunocompromised, post operative or poor surgical candidates. Percutaneous drainage cures infected fluid or air collections in more than 80% of patients, which supports strong clinical adoption. The procedure also provides diagnostic value because aspirated fluid can be sent for microbiology, cytology or biochemical testing. Growth will be strongest in hospitals that are expanding interventional radiology capacity, emergency imaging access and minimally invasive procedural pathways. Catheter demand will increasingly follow imaging guided care expansion rather than traditional operating room volume alone.

Biliary Drainage Catheter Demand 

Biliary drainage catheters remain the largest product opportunity because biliary obstruction and hepatobiliary disease often require decompression when endoscopic or surgical routes are delayed, unsuitable or incomplete. External and internal external biliary drainage catheters are used to relieve jaundice, cholangitis and obstruction caused by malignancy, strictures, stones or post surgical complications. The DataM Intelligence page identifies biliary drainage catheters as the dominant product segment, supported by catheter security, guidewire exchange capability and access for adjunctive treatment of benign or malignant strictures. Demand is strongest in tertiary hospitals, oncology centers and interventional radiology suites managing pancreatic cancer, cholangiocarcinoma, gallbladder cancer and complex biliary obstruction. Growth is also supported by aging populations and higher diagnosis of hepatobiliary cancers. Suppliers with broad catheter sizes, internal external configurations and strong radiopaque visibility will capture higher share in biliary drainage.

Nephrostomy and Urologic Drainage Growth

Nephrostomy drainage is a major growth area for percutaneous drainage catheters because urinary obstruction, kidney stones, infection, malignancy and post surgical complications require urgent decompression in many cases. Percutaneous nephrostomy places a catheter into the renal collecting system under image guidance to drain urine and protect renal function. Kidney stone disease supports long term procedure demand because stones affect up to 12% of the population during a lifetime and recurrence rates approach 50% at 10 years. Malignant ureteral obstruction, infected hydronephrosis and complex stone disease also support catheter use. Nephrostomy catheters must balance drainage efficiency, secure pigtail retention, patient comfort and resistance to blockage or dislodgement. The segment is shifting toward smaller profile catheters, better locking mechanisms, hydrophilic coatings and securement solutions. Growth will be strongest in hospitals with active urology, oncology and emergency interventional radiology programs.

Abscess and Post Surgical Collection Drainage Demand

Abscess drainage is a core application because intra abdominal, pelvic, thoracic, musculoskeletal and post surgical collections are frequent drivers of hospital admission and interventional radiology consults. CT guided drainage is especially important when deep collections are difficult to access with ultrasound due to bowel, bone or vascular structures. The American College of Radiology has reported around 80% success for CT guided percutaneous abscess drainage, defined as complete drainage without further procedures. Catheter selection depends on fluid viscosity, collection size, location, septations and access route. Complex collections may need larger bore catheters, multiple drains, flushing or catheter exchanges. Growth is linked to rising abdominal surgeries, oncology procedures, pancreatitis, diverticular disease and complicated appendicitis. Manufacturers that improve catheter flow, anti kinking performance and easy exchange capability will gain advantage. Abscess drainage will remain a high volume and clinically essential use case.

Centesis Drainage and Recurrent Fluid Management 

Centesis drainage catheters are gaining relevance in recurrent fluid management across pleural effusion, ascites and other symptomatic fluid collections. These procedures support rapid symptom relief and can be performed in hospitals, ambulatory settings or specialized drainage programs. Cancer related pleural effusion and ascites are important demand drivers because patients often require repeat drainage or longer term fluid control. The market is moving toward drainage solutions that improve patient comfort, reduce repeated needle punctures and support easier fluid evacuation. In palliative oncology and chronic disease care, catheter selection must consider infection risk, leakage, securement, patient mobility and home drainage training. Growth will be strongest where hospitals shift repeat drainage from inpatient care toward outpatient or home supported models. Suppliers that combine catheter systems with drainage kits, securement devices and patient friendly accessories can create stronger recurring demand.

Percutaneous Drainage Catheter Design Innovation

Catheter design innovation is a major market driver because drainage performance depends on lumen design, side hole geometry, pigtail configuration, material flexibility, radiopacity and kink resistance. The DataM Intelligence page highlights device advancement as a growth driver, including newer designs such as 3D pigtail drainage catheters and dual lumen drainage catheter concepts with dedicated flush lumen irrigation for complicated fluid collections. Smaller profile locking catheters are also gaining attention because they allow placement into smaller fluid pockets and may improve patient comfort. Merit Medical’s ReSolve Mini Locking Drainage Catheter is positioned around a mini pigtail design up to 42% smaller than the conventional ReSolve locking catheter pigtail. Innovation is increasingly focused on preventing clogging, reducing dislodgement, supporting easier catheter exchange and improving drainage completeness. Suppliers with strong flow performance and secure placement will gain higher procedural preference.

Percutaneous Drainage Catheter Failure Analysis

Catheter related complications remain a central restraint because drainage catheters can clog, dislodge, kink, migrate or require replacement. Clinical risks also include bleeding, organ injury, bacteremia, septic shock and infection of previously sterile fluid collections. Interventional radiology patient guidance reports bacteremia in 2% to 5% of cases and septic shock in 1% to 2% of cases. Failure occurs in 5% to 10% of infected fluid or air collection drainage cases. These risks directly shape product design because clinicians need catheters that remain stable after placement and maintain flow over multiple days. Securement systems, locking pigtails, anti kinking shafts and clear radiographic markers are becoming more important. The market will reward devices that reduce reintervention, replacement and nursing burden. Suppliers that can prove lower clogging and dislodgement rates will gain traction with hospitals focused on quality improvement.

Percutaneous Drainage Catheter End User Analysis

Hospitals remain the largest end user because most percutaneous drainage procedures require imaging suites, interventional radiologists, nursing teams, sedation support and post procedure monitoring. However, selected drainage care is shifting toward ambulatory surgical centers, outpatient interventional radiology centers and home drainage management. This is especially relevant for recurrent effusions, ascites, stable abscess follow up and catheter maintenance. Outpatient pathways reduce bed pressure and support cost control, but they require reliable catheter securement, patient education, infection prevention and drainage supplies. The shift increases demand for complete drainage kits, home compatible accessories, dressing systems and clear catheter care protocols. Ambulatory adoption will depend on payer coverage, imaging availability and clinical risk selection. Manufacturers that design catheters and drainage accessories around outpatient workflow will be better positioned as healthcare systems move suitable procedures away from inpatient settings.

Asia Pacific Procedure Expansion Analysis

Asia Pacific is the fastest growing region because hospitals across India, China, Southeast Asia and other markets are expanding imaging, interventional radiology and minimally invasive procedural capacity. Rising cancer diagnosis, hepatobiliary disease, kidney stones, trauma care and post surgical complication management are increasing the need for drainage procedures. Many hospitals are upgrading from surgical drainage or conservative management toward image guided catheter drainage as CT, ultrasound and fluoroscopy access improves. Growth is also supported by expanding private hospital networks and stronger patient preference for shorter recovery. Price sensitivity remains important, which creates opportunities for local manufacturers of pigtail, biliary and nephrostomy catheters. Premium suppliers can still win in tertiary centers where oncology, transplant, hepatobiliary surgery and advanced IR programs require high performance devices. Asia Pacific growth will be shaped by training, affordability and product availability.

Percutaneous Drainage Catheter White Space Opportunities 

White space exists in three areas: small collection drainage, clog resistant catheters and home based drainage support. Small fluid pockets are difficult to access with conventional pigtail designs, creating demand for mini locking catheters and lower profile systems that can be placed precisely. Complex infected collections create another opportunity because thick or loculated fluid can clog conventional catheters and require repeated flushing or exchanges. Dual lumen designs, enhanced side holes, dedicated irrigation channels and anti biofilm materials can improve drainage reliability. Home based drainage is a third opportunity because recurrent effusion, ascites and longer term catheter care need better securement, dressing, patient training and digital monitoring support. Emerging markets also offer white space for affordable standardized drainage kits. The strongest unmet need is a full procedure to recovery solution that reduces placement difficulty, clogging, dislodgement and post discharge catheter care burden.

Percutaneous Drainage Catheter Investment Scenario

Investment interest in percutaneous drainage catheters will concentrate around companies that improve procedural efficiency, recurring consumable demand and outpatient drainage management. The market is attractive because it sits within interventional radiology, a specialty expanding across oncology, infection management, urology and minimally invasive care. Investors should prioritize businesses with differentiated catheter design, strong hospital relationships, regulatory approvals and broad portfolios across biliary, nephrostomy, abscess and centesis drainage. Companies with securement systems, drainage bags, home care kits and catheter maintenance accessories can capture recurring revenue beyond the initial procedure. Asia Pacific expansion creates another investment scenario because high procedure growth and local manufacturing demand support both premium imports and cost effective domestic products. Risks include price competition, group purchasing pressure, product commoditization and clinical liability from catheter failure. Attractive targets will have IP around locking design, anti clogging flow architecture or complete drainage care platforms.

Percutaneous Drainage Catheter Competitive Positioning

Competitive positioning is defined by catheter breadth, brand trust, IR physician familiarity, distribution reach, kit completeness and product reliability. Cook Medical has a strong position through multipurpose, biliary and drainage catheter portfolios. Merit Medical is important through ReSolve drainage catheters, Aspira systems and innovation around mini locking designs. BD, Boston Scientific, Teleflex, Argon Medical Devices, Medical Components and regional manufacturers compete across drainage catheters, access kits, needles, guidewires, drainage bags and related accessories. Hospitals value suppliers that offer complete procedural compatibility across Seldinger and trocar techniques. Product differentiation is shifting toward stability, kink resistance, radiopaque visibility, secure locking, flow performance and ease of exchange. Companies that can support both inpatient IR suites and outpatient drainage programs will gain advantage. The market will increasingly favor suppliers that combine device performance with workflow support and reliable supply.

Major Recent Percutaneous Drainage Catheter News

• In May 2026, Merit Medical Systems highlighted continued advancement of its ReSolve Drainage Catheter portfolio and Aspira drainage systems. The focus on securement technologies, drainage efficiency and long term drainage management supports the market shift toward minimally invasive image guided care and home based patient support.
• In April 2026, Merit Medical Systems reported continued innovation across its ReSolve ConvertX Stent System, ReSolve Mini Locking Drainage Catheter and One Step Drainage Catheters. The developments are important because clinicians need catheters that improve placement stability, ease of use and fluid evacuation in interventional radiology procedures.
• In 2026, product development across the wider percutaneous drainage catheter category continued to focus on anti kinking designs, improved catheter materials, optimized side hole geometry, securement systems and better drainage flow. This reflects a clear market response to clogging, migration, dislodgement and repeat intervention risk.
• Clinical interest remained strong in percutaneous cholecystostomy for high surgical risk acute cholecystitis patients. Around 10,000 nonsurgical candidates per year in the United States are reported to receive gallbladder decompression through percutaneous cholecystostomy, supporting biliary and gallbladder drainage catheter demand in high acuity hospital settings.

Fast Growing Use Cases for Percutaneous Drainage Catheters

1. Image Guided Abscess Drainage

Image guided abscess drainage is one of the fastest growing use cases because hospitals are using minimally invasive drainage to treat infected abdominal, pelvic, thoracic and post surgical collections. The procedure can avoid open surgical drainage in appropriate patients and provides both therapeutic and diagnostic value. Percutaneous drainage cures infected fluid or air collections in more than 80% of patients, making it a strong clinical pathway for interventional radiology. Growth is strongest in tertiary hospitals, emergency settings and post operative complication management. The market is moving toward catheters with better flow, anti kinking shafts, secure locking pigtails and designs that reduce repeat intervention.

2. Nephrostomy Drainage for Urinary Obstruction

Nephrostomy drainage is a fast growing use case because kidney stones, malignancy, infection and ureteral obstruction often require urgent decompression. Kidney stones affect up to 12% of the population during a lifetime and recurrence rates approach 50% at 10 years, creating a large recurring urologic disease base. Percutaneous nephrostomy catheters must maintain reliable urine drainage while reducing dislodgement, leakage and blockage. Growth is strongest in hospitals with active urology, oncology and emergency care programs. The market is moving toward smaller profile, secure and exchange friendly nephrostomy catheters that improve patient comfort and procedural efficiency.

3. Biliary Drainage in Obstruction and Cholangitis

Biliary drainage is a high growth use case because malignant obstruction, benign strictures, cholangitis and post surgical complications often require catheter based decompression. Biliary drainage catheters are especially important when endoscopic drainage is unsuitable or when patients need external or internal external access for ongoing management. Demand is strongest in oncology centers, hepatobiliary units and tertiary hospitals treating pancreatic cancer, cholangiocarcinoma and gallbladder disease. Catheter security, side hole placement, radiopaque visibility and guidewire exchange capability are key buying criteria. The market is moving toward biliary drainage systems that support better patient mobility, easier exchange and lower complication burden.

What You Get Compared with Competitors